Navigation Links
Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
Date:11/6/2012

BOULDER, Colo., Nov. 6, 2012 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) announced that an abstract discussing the final Phase 2 trial results with ARRY-797 in patients with osteoarthritis pain will be presented at the 2012 American College of Rheumatology Annual Meeting in Washington, D.C. This abstract includes data on ARRY-797's analgesic effect and markers of disease modification.  In addition, biomarkers of cartilage (COMP) and bone (CTX‑I) degradation were assessed. ARRY‑797 treatment resulted in statistically significant decreases in COMP and CTX‑I at week 4 (decreases of 10% and 38% versus placebo, respectively). The decrease in CTX‑I was sustained and returned to baseline by the follow‑up visit.  The abstract concludes that further evaluation of the potential for disease modifying activity is warranted. 

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

The abstract can be accessed through the American College of Rheumatology Annual Meeting website, http://www.rheumatology.org/apps/MyAnnualMeeting/ExploreMeeting.  After the presentation, the poster will be available as a PDF on Array's website at www.arraybiopharma.com. Poster:A Randomized, Placebo-Controlled Phase 2 Study of ARRY-797 in Patients with Osteoarthritis Pain Refractory to NSAID Treatment Showed Statistically Significant Improvements in WOMAC Pain and in Biomarkers of Bone and Cartilage DegradationSession:Late Breaking AbstractsDate:Tuesday, November 13, 2012Time:9:00 - 11:00 AM Eastern TimeLocation:Walter E. Washington Convention Center - Poster Hall (Hall B)Array announced in July 2012 that ARRY-797, a non-opioid, met its primary e
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
2. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
3. PDL BioPharma Announces Third Quarter 2012 Financial Results
4. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
5. New Study Highlights Enabling Factors for Biopharmaceutical Innovation in Middle-Income Countries
6. SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
7. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
8. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
9. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
10. PDL BioPharma Completes Regular Quarterly Dividend Payment
11. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Torrance Memorial Medical ... advanced, ventilator technology from Covidien to provide a ... patients. The acute care ventilator is ... to conventional mechanical ventilation, and help clinicians move ... Patients on mechanical ventilation are often sedated to ...
(Date:8/20/2014)... 2014 Transparency Market ... Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid ... Share, Growth, Trends and Forecast 2014 - 2020". The ... million in 2013 and is anticipated to reach USD ... 3.6% during the forecast period from 2014 to 2020. ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a new ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for ... the following Product Segments: Active Coatings, Protective Coatings, ... separate comprehensive analytics for the US, ...
Breaking Medicine Technology:Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
(Date:8/20/2014)... Caddis Partners LLC, has built one of the ... company in recent years, developing or acquiring 2 million ... including more than $100 million last year alone. , ... new geographic regions and a wider array of product ... announce an enhanced brand identity that includes a new ...
(Date:8/20/2014)... August 20, 2014 Braverman Eye Center ... help of their experienced surgeons trained in PresbyLasik. The ... regain their lost or inaccurate vision. Their diligent service ... surgery is making it possible for Presbyopia patients to ... occurs normally in people in the age group of ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Texas Medical Research ... study. The study will help test the effectiveness of a ... from high cholesterol may be eligible to participate in the ... cholesterol in the blood can lead to cardiovascular disease, the ... cholesterol can help reduce the risk of heart disease and ...
(Date:8/20/2014)... Transrectal ultrasound guided biopsy is the gold standard for ... the number of risks associated with the procedure is ... found that six percent of men filled a prescription ... days after having a prostate biopsy, with a twofold ... The Journal of Urology . , Earlier studies reported ...
(Date:8/20/2014)... to predict both breast cancer relapses and responses ... gene. The newly found marker could help doctors ... treatment regimen that is more effective. The discovery ... Institute of Molecular and Cell Biology (IMCB), and ... at the National University of Singapore (NUS). , ...
Breaking Medicine News(10 mins):Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2Health News:Texas Medical Research Associates Announce New Study 2Health News:Severe infections with hospitalization after prostate biopsy rising in Sweden 2Health News:Novel gene predicts both breast cancer relapse and response to chemotherapy 2
... ,It,s Totally Glam to Go for a Mammogram, and ... Men ,Don,t Wait to Check Your Prostate, DALLAS, ... across Texas are sending a different kind of love note to ... women can send an e-reminder to,schedule important cancer screenings that will ...
... ... ... it has begun shipping the new SILVER SEAL(TM) Washable, Antimicrobial,Keyboard. According ... keyboard to be fully submersible, dishwasher safe,and manufactured from SILVER SEAL(TM) ...
... ARLINGTON, Va., Feb. 12 As health care,continues ... election, The HealthCentral,Network, Inc.,s ( http://www.HealthCentral.com ) interactive ... credible tool for voters to determine,which candidate aligns ... Now, washingtonpost.com has chosen the tool for its ...
... 12 Thanks to the collective spirit,of three ... new event has been added to the 2008 ... Triathlon, and registration,is now open., The Ramblin, ... empowerment of women, bring together women of all ...
... a,leading provider of evidence-based nutraceuticals for eye health, today,announced ... its Scientific,Advisory Board., Dr. Coleman is a Professor ... David Geffen School of Medicine at UCLA as well ... Health. She holds,the Frances and Ray Stark Endowed Chair ...
... Transitions, ... Feb. 12 In an effort to heighten,consumer awareness ... debuting a new print, broadcast and digital integrated advertising,campaign ... TV and in print,and will be supported by the ...
Cached Medicine News:Health News:'His and Hers' Screening Campaign Offers Unique Valentine's Day Message to Increase Cancer Screenings and Promote Health 2Health News:'His and Hers' Screening Campaign Offers Unique Valentine's Day Message to Increase Cancer Screenings and Promote Health 3Health News:Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard 2Health News:Healthcentral's Healthcare08 Site, an Interactive Health Care Issues Tool, Featured on washingtonpost.com 2Health News:An Event Added to Celebrate and Empower North Carolina Women 2Health News:ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board 2Health News:Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site 2Health News:Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: